Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature

DOI: 10.4292/wjgpt.v8.i3.155

Keywords: Inflammatory bowel disease, Adalimumab, Anti-tumor necrosis factor, Infliximab, Therapeutic drug monitoring, Drug antibody, Antidrug antibodies, Dose escalation

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text